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SUMMARY
Exercise has beneficial effects on metabolism and on tissues. The exercise-induced muscle factor 
β-aminoisobutyric acid (BAIBA) plays a critical role in the browning of white fat and in insulin 
resistance. Here we show another function for BAIBA, that of a bone-protective factor that 
prevents osteocyte cell death induced by reactive oxygen species (ROS). L-BAIBA was as or more 
protective than estrogen or N-acetyl cysteine, signaling through the Mas-Related G Protein-
Coupled Receptor Type D (MRGPRD) to prevent the breakdown of mitochondria due to ROS. 
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BAIBA supplied in drinking water prevented bone loss and loss of muscle function in the murine 
hindlimb unloading model, a model of osteocyte apoptosis. The protective effect of BAIBA was 
lost with age, not due to loss of the muscle capacity to produce BAIBA but likely to reduced 
Mrgprd expression with aging. This has implications for understanding the attenuated effect of 
exercise on bone with aging.
Graphical abstract
INTRODUCTION
Clearly, exercise has beneficial effects on many systems in the body, such as the neural, 
metabolic, and musculoskeletal systems (Blair et al., 1995, but it is not clear if these benefits 
delay the effects of aging or if aging blunts the effects of exercise. Sarcopenia and 
osteoporosis are major hallmarks of the aging musculoskeletal system, resulting in frailty, 
falls, fracture, and morbidity. It is predicted that 1 in 5 individuals will be over the age of 65 
by 2020 (Benefield and Holtzclaw, 2014); therefore, it becomes imperative to understand 
these two co-morbidities in order to prevent both muscle and bone weakness.
Bone and muscle have an intimate relationship and show synchronization of tissue mass 
throughout life, from development to old age (Brotto and Bonewald, 2015). Exercise 
maintains or increases both bone and muscle mass, whereas disuse results in a reduction in 
mass/function of both tissues. Exercise has less of an anabolic effect on the bone with aging. 
Muscle and bone clearly have a mechanical interaction, with muscle loading the bone for 
locomotion, but recently it has been shown these tissues communicate through secreted 
factors. Factors have been identified as secreted by bone cells, such as osteocalcin (Karsenty 
and Olson, 2016), and secreted by osteocytes, such as prostaglandins (Mo et al., 2012) and 
WNTs (Huang et al., 2017), which have effects on muscle. Contracted muscle-derived 
factors, such as insulin growth factor-1 (IGF-1), fibroblast growth factor-2 (FGF-2) 
(Hamrick et al., 2010), interleukin-15 (IL-15) (Nielsen et al., 2007), and irisin (Colaianni et 
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al., 2015), have osteogenic effects. In contrast, disuse-induced muscle atrophy produces 
myostatin that has anti-osteogenic effects by decreasing osteoblastogenesis (Qin et al., 2017) 
and increasing osteoclastogenesis (Dankbar et al., 2015). These findings support the concept 
of muscle/bone communication.
Our group has focused on the bone cell embedded in the bone matrix, the osteocyte. 
Osteocytes derive from a subpopulation of osteoblasts by the embedding into the newly 
formed bone and the formation of a global mechanosensory cellular network inside the bone 
matrix. This cell has come from obscurity a decade ago to being recognized as a 
multifunctional cell (Bonewald, 2011) that can regulate osteoclasts, the bone-resorbing cells, 
through RANKL expression (Nakashima et al., 2011; Xiong et al., 2015), and osteoblasts, 
the bone-forming cells, through sclerostin production (van Bezooijen et al., 2004) and 
WNT1 (Joeng et al., 2017). Osteocytes as endocrine cells have been shown to target the 
kidney through fibroblast growth factor-23 (Feng et al., 2003) by binding the FGF receptor/
Klotho complex (Urakawa et al., 2006) to regulate phosphate excretion by the kidney. 
Unlike osteoblasts and osteoclasts, which are viable from days to a few weeks, osteocytes 
are viable for decades in the bone matrix. Osteocyte death can signal resorption and 
remodeling of bone; therefore, maintenance of osteocyte viability requires tight control. A 
number of factors have been shown to cause osteocyte cell death, such as IL-1, tumor 
necrosis factor alpha (TNF-α), glucocorticoids, reactive oxygen species (ROS), and others, 
and to prevent the effects of these factors, a number of protective factors have been shown to 
prevent osteocyte cell death, such as estrogen, parathyroid hormone, N-acetyl cysteine 
(NAC), and others (Jilka et al., 2013). However, these protective factors are not regulated by 
exercise, so we postulated that muscle secretes osteocyte-protective factors in response to 
contraction. We had previously shown that muscle is a source of osteocyte-protective factors, 
and we showed that contracted muscle secretes factors that protect osteocytes against 
glucocorticoid-induced cell death (Jähn et al., 2012). Here we identify β-aminoisobutyric 
acid (BAIBA) as a major osteocyte-protective factor.
In 2014, BAIBA was described as a small (103.6-Da) molecule produced by skeletal muscle 
during exercise (Roberts et al., 2014), and it was shown to signal the beneficial effect of 
exercise from skeletal muscle to other tissues and organs in an endocrine manner. BAIBA 
increases energy expenditure by activating the β-oxidation pathway of hepatic fatty acid, 
triggers the browning of white adipose tissue, is inversely correlated with cardiometabolic 
risks factors (Roberts et al., 2014), and improves insulin resistance and inflammation in 
skeletal muscle in an autocrine/paracrine manner (Jung et al., 2015). More recently, the 
molecule has been shown to reduce hepatic endoplasmic reticulum (ER) stress and glucose/
lipid metabolic disturbance in type 2 diabetes (Shi et al., 2016) and to ameliorate renal 
fibrosis, in a mouse model of obstructed kidney, via the inhibition of renal fibroblast 
activation and fibrosis (Wang et al., 2017).
Here we describe another function for BAIBA as a muscle-secreted factor that protects 
osteocytes against ROS and can prevent both bone and muscle loss in vivo. We identified 
and describe the mechanism used by this factor to protect osteocytes, via signaling through 
the Mas-related G protein-coupled receptor type D (MRGPRD), to prevent mitochondrial 
breakdown in osteocytes. We also describe how this function of BAIBA is lost with aging, 
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not through the muscle capacity to produce BAIBA with contraction but through the 
downregulation of this receptor in osteocytes. These findings have implications for 
correcting reduced skeletal response to exercise with aging and for muscle-bone interactions 
during aging.
RESULTS
Muscle Secretes Osteocyte-Protective Factors
Previously we hypothesized that muscle and bone communicate through soluble factors 
(Bonewald et al., 2013), and then we showed that osteocytes produce factors that support 
myogenesis and muscle function (Mo et al., 2012) and that muscle secretes osteocyte-
protective factors (Jähn et al., 2012). As C2C12 myotube conditioned media (CM) mimicked 
the effects of extensor digitorum longus (EDL) and soleus (SOL) CM (Figure 6 of Jähn et 
al., 2012) with regard to osteocyte-protective capability, a series of fractionation experiments 
were performed. The bioactivity was less than 10 kDa (even less than 3 kDa), resistant to 
trypsin and boiling, and partially degraded by UV light over time (Figures S1A and S1B). 
As we have demonstrated previously that PGE2 is a potent anti-apoptotic agent and is highly 
expressed by osteocytes in response to fluid flow shear stress (Kitase et al., 2010), we 
measured PGE2 levels in muscle CM. CM from C2C12 myoblasts or myotubes and both 
EDL and soleus with and without contraction presented with low levels of PGE2, insufficient 
to have an effect on osteocytes (MLO-Y4 cells subjected to 2 dynes/cm3 fluid flow shear 
stress produced 18,353 ± 1,969, C2C12 myotube-CM 168 ± 10, and C2C12 myoblast-CM 
63 ± 4 PGE2 pg/106 cells; experiments were repeated 3 times with similar results).
As ROS are elevated with aging, we next determined if muscle-secreted factors could protect 
against ROS-induced osteocyte cell death. Both static and contracted EDL and soleus CM 
were protective (Figure S2). We screened a number of small molecular weight molecules 
secreted by muscle, including BAIBA, for their protective capacity using the osteocyte cell 
line MLO-Y4, and BAIBA was the most potent (Figure 1A). The L-isoform was shown to be 
the more active form compared to the D-isoform (Figure 1A), and L-BAIBA was as or more 
potent than the well-known anti-apoptotic factors β-estradiol and NAC (Figure 1B). ROS 
was shown to be reduced by both L-BAIBA and the positive control NAC (Figure 1C). 
Catalase and Gpx4, known to protect against ROS, were increased in response to L-BAIBA, 
similar to NAC (Figure 1D). We have also examined the protective effect of BAIBA on 
osteoblasts as precursors of osteocytes using an osteoblast cell model, MC3T3-E1, and we 
found that it also prevented them from cell death induced by hydrogen peroxide (Figure S3).
L-BAIBA Protects against Bone and Muscle Loss due to Disuse
To understand the in vivo relevance of the cellular effects determined in vitro, experiments 
were performed using the established murine hindlimb unloading model in which the 
detrimental effects of unloading on bone mass through apoptotic osteocytes is well described 
(Basso and Heersche, 2006). Blocking osteocyte apoptosis using an apoptosis inhibitor has 
been shown to prevent bone loss induced by hindlimb unloading (Cabahug-Zuckerman et al., 
2016). As BAIBA production is increased with exercise (Roberts et al., 2014), the hindlimb 
unloading assay, a model for disuse or lack of exercise, was performed to determine if 
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BAIBA could prevent bone loss. Hindlimb unloading was performed for 2 weeks on paired 
5-month-old males or 3-month-old females with or without 100 mg/kg/day L-BAIBA added 
to drinking water (3-month-old females were chosen because of almost complete loss of 
trabecular bone by 5 months of age).
At baseline, both groups showed no statistical differences in trabecular parameters in the 
tibial metaphysis. Also at baseline, both groups showed no statistical differences in Ellipsoid 
factor (EF) values categorized in each structure showing plate-type-dominated structures 
(control, 50.3% ± 6.8%; L-BAIBA, 45.1% ± 7.6% in male; control, 31.2% ± 11.4%; L-
BAIBA, 38.912.42% in female) and intermediate structures (control, 49.5% ± 6.8%; L-
BAIBA, 54.4% ± 7.8% in male; control, 64.0% ± 11.7%; L-BAIBA, 59.8% ± 15.4% in 
female). In vivo micro computed tomography (μCT) analysis at two time points showed that 
hindlimb-unloaded mice given L-BAIBA have significantly higher bone volume fraction 
(BV/TV), and higher thickness and connectivity of trabecular bones compared to control 
group that was gender-independent (Figures 2A–2E). Ex vivo μCT analysis confirmed the in 
vivo μCT data (Figures 2F–2J). EF analysis revealed more plate-type-dominated structures 
retained in males after 2-week hindlimb unloading, while bone in the control group shifted 
to more intermediate structures. No differences in EF analysis in female mice were observed 
(Figures 2K–2N). By histological analysis, bone parameters were generally consistent with 
μCT data as shown in Figure 2, and, while there was no effect on osteoclast parameters in 
both males and females, osteoblast number and surface were significantly higher in male L-
BAIBA-treated animals (Figures 3A–3H). Similar to the ex vivo μCT data shown in Figure 
2, there was a significant difference, higher BV/TV, trabecular number (Tb.N), and 
trabecular thickness (Tb.Th.) and lower trabecular separation (Tb.Sp.), in treated compared 
to control males. Unlike the μCT data in Figure 2, no significant differences were observed 
in bone parameters in females. Significantly greater apoptosis was observed in osteocytes in 
the untreated as compared to the L-BAIBA-treated animals (Figure 3I). Real-time PCR did 
not show a significant change in Rankl, Opg, and Sost mRNA obtained from femurs (Figure 
3J).
To determine if the administration of L-BAIBA has an additional effect on muscle function 
in the disuse model, ex vivo contractility of the EDL (mainly consisting of glycolytic muscle 
fibers) and of the soleus (mainly consisting of oxidative muscle fibers) muscles was 
performed. EDL showed significantly greater muscle mass and maximal tetanic force in 
male mice receiving L-BAIBA over controls (Figures 4A and 4B). A significant difference 
in soleus half-maximal force and rate of force development was observed in L-BAIBA-
treated males (Figures 4H and 4J). Additionally, the force-frequency relationship of soleus 
from male mice treated with L-BAIBA showed higher relative forces at stimulatory 
frequencies in the range of 40–80 Hz compared to non-treated controls (Figure 4L). 
Interestingly, EDL and soleus muscles from female mice were virtually unaffected by L-
BAIBA treatment (Figures 4A–4L).
L-BAIBA Is Produced by Both Young and Old Contracted Muscle
To determine if BAIBA is produced by both young and aged muscle, CM were obtained 
from both EDL and soleus muscles dissected from male and female mice, 5 and 22 months 
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old, with and without contraction at 90 Hz. Muscle CM were freeze-dried, derivatized using 
Marfey’s reagent, and then quantitated by liquid chromatography-mass spectrometry (LC-
MS) as described previously (Vemula et al., 2017). Contraction stimulated L-BAIBA 
production in all muscle, EDL and soleus, male and female, but to a greater extent in aged 
muscle compared with young muscle (Figure 5A). There were no significant changes in 20 
amino acids or in the BAIBA analogs, such as γ-aminobutyric acid (GABA) (Figures S4A 
and S4B).
L-BAIBA Protects Young, but Not Old, Osteocytes from ROS-Induced Cell Death
To begin to determine if BAIBA might function as an osteocyte-protective agent with aging, 
osteocytes from both 5- and 22-month-old male and female mice were tested. L/D-BAIBA 
and L-BAIBA blocked the negative effects of ROS on young, but not old, osteocytes 
(Figures 5B and 5C).
L-BAIBA Signals through the MRGPRD to Protect Osteocytes from Cell Death
As old muscle was just as capable as young muscle to secrete L-BAIBA in response to 
contraction, we asked if the receptor for BAIBA could be affected by aging. Mas-related G 
protein-coupled receptor type D (Mrgprd) and glycine receptors, both known BAIBA 
receptors, were examined in primary bone cells. The Mrgprd was highly expressed in 
primary osteocytes especially at 5 months of age (Figure 6A). Expression increased from 2.5 
months to 5 months and highly decreased by 22 months of age. The expression level was 
higher in males compared to females. These receptors were more highly expressed in the 
primary osteocyte population compared to primary osteoblasts (Figure 6A). Glycine 
receptors (Glra4 and Glrb) were expressed at lower levels than the Mrgprd (Figure 6B). 
Even though the Glrb was highly expressed in MLO-Y4 cells, there was a little expression 
of its potential subunit, Glra4, that was dimerized to form their functional receptor (Figure 
6C). Glra1–3 were not detectable. Other ligands for these receptors include β-alanine and 
GABA, so these were compared to L-BAIBA for osteocyte-protective capacity. L-BAIBA 
was approximately 100-fold more potent than β-alanine, GABA, or glycine (Figure 6D). To 
determine if MRGPRD is the functional receptor for BAIBA, inhibitory assays were 
performed. The receptor antagonist for MRGPRD, MU6840, significantly attenuated the 
activity of L-BAIBA (Figure 6E). Experiments were performed using small interfering RNA 
(siRNA) and CRISPR technology for knockdown studies. Mrgprd-targeted siRNA was 
shown to completely block the expression of mRNA (Figure 6F) and reverse the positive 
effects of L-BAIBA on H2O2-induced cell death (Figure 6G). Two different Mrgprd single 
guide RNAs (sgRNAs) were shown to significantly reduce protein expression of MRGPRD 
(Figure 6H) and to significantly block the positive effects of L-BAIBA on H2O2-induced cell 
death (Figure 6I). Therefore, based on inhibitor and knockdown studies, the MRGPRD 
appears to be the receptor mediating the protective effects of L-BAIBA on osteocytes.
Mitochondria Movement and Dynamics in Osteocytes
Next, we asked how L-BAIBA maintains osteocyte viability. Osteocytes have been imaged 
previously in vivo for active mitochondria using Tetramethylrhodamine, ethyl ester, TMRE, 
a cell-permeant, cationic, red-orange fluorescent dye that is readily sequestered by active 
mitochondria (Frikha-Benayed et al., 2016). These investigators suggested that osteocytes 
Kitase et al. Page 6
Cell Rep. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
with impaired mitochondrial function may be more susceptible to apoptosis. As 
mitochondria are known to produce ROS as a by-product along with the production of ATP, 
we decided to determine if mitochondria might be involved in the protective effects of 
BAIBA on H2O2-induced cell death. Using Mito Red, we found that mitochondria can be 
imaged over time in MLO-Y4 cells and mitochondria can be observed moving in the 
dendritic processes, similar to that observed with oligodendrocyte primary processes and 
neuronal dendrites (Rinholm et al., 2016) (Figure 7A; Movies S1 and S2). Primary 
osteocytes isolated from Dmp1-GFP mice showed similar properties with regard to 
mitochondrial movement (Figure 7A; Movie S3).
L-BAIBA Prevents Mitochondrial Breakdown due to ROS
To determine if L-BAIBA would prevent the negative effects of ROS on mitochondria, time-
lapse imaging experiments were performed. When H2O2 (100 μM) was applied to MLO-Y4 
osteocyte-like cells, unopposed fission occurred over 50 min along with reduced TMRE 
intensity (Figure 7B), but this effect was blocked by L-BAIBA (Figures 7C and 7D). To 
quantitate the mitochondrial functional status, cells were stained with TMRE, which is 
fluorescent only in functional mitochondria, and with mitoD, which stays fluorescent 
whether the mitochondria are functional or not. The ratio of TMRE/mitoD, which is related 
to mitochondrial membrane potential, is shown in Figures 7E–7G. This ratio was 
significantly reduced with H2O2, while L-BAIBA pretreatment maintained the same ratio in 
response to H2O2 as non-treated cells. Therefore, L-BAIBA appears to protect osteocytes 
through the maintenance of their mitochondria. Not only does L-BAIBA have short-term 
effects on mitochondria integrity but also it regulates mitochondrial gene expression (Figure 
S5).
DISCUSSION
The effects of muscle on bone were previously thought to be exclusively mediated through 
mechanical loading, however, here we show that, in addition, the muscle can have effects on 
bone through a secreted metabolite, BAIBA. Others have shown that muscle can secrete 
factors that have effects on other tissues. Originally these factors were termed myokines and 
shown to be secreted proteins (Pedersen, 2011). Exercise has been shown to stimulate 
skeletal muscle to secrete soluble factors that modulate bone metabolism, such as IGF-1 and 
FGF-2 (Hamrick et al., 2010) and irisin, which has been shown to increase bone mass 
(Colaianni et al., 2015). We proposed that muscle would secrete proteins that would protect 
osteocytes from cell death (Jähn et al., 2012), but we found a small molecular weight 
molecule, a metabolite, was responsible. Both the slow-twitch oxidative muscle, such as 
soleus, and fast-twitch glycolytic muscles, such as EDL, secrete BAIBA when contracted. 
BAIBA was found to be as or more potent than known protective factors β-estradiol and 
NAC.
BAIBA is a small molecule produced by skeletal muscle during exercise (Roberts et al., 
2014). BAIBA consists of two enantiomers, L-BAIBA and D-BAIBA. This non-protein β-
amino acid, L-BAIBA, is produced from the utilization of a branched amino acid L-valine as 
an energy source under the control of transcriptional co-activator PGC-1α. BAIBA was 
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shown to be a mediator of the beneficial effect of exercise from skeletal muscle to other 
tissue organs in an endocrine manner. It activates the β-oxidation pathway of hepatic fatty 
acid, and it triggers the browning of white adipose tissue (Roberts et al., 2014), improves 
insulin resistance and inflammation in skeletal muscle in an autocrine/paracrine manner 
(Jung et al., 2015), prevents diet-induced obesity (Begriche et al., 2008), and protects against 
metabolic disturbance in type 2 diabetes (Shi et al., 2016). We have now shown another 
function for this muscle metabolite, that of protecting osteocytes from cell death. In vivo, 
this metabolite retains bone and muscle with unloading apparently through this mechanism.
Every amino acid except glycine has two enantiomers. Usually naturally occurring amino 
acids in cells are the L-form, not the D-form. However, D-BAIBA is derived from thymine 
and excluded in the urine (Smith and Dymond, 1963). We determined the greater potency of 
the L-form compared to the D-form on osteocyte viability (Figure 1A). We have also shown 
that L-BAIBA, but not D-BAIBA, is produced by contracted muscle regardless of skeletal 
muscle type, gender, and age (Figure 5A). As far as we know, the different enantiomers have 
not been tested on the MRGPRD signaling, but, based on our results, it is assumed that the 
L-form is the biologically active form that binds to this receptor.
Osteocytes are one of the longest-lived cells in the body, remaining viable in the bone matrix 
for decades (Manolagas and Parfitt, 2013). Osteocyte viability is crucial for the normal 
functioning of the skeleton and potentially for the normal function of other organs, such as 
kidney and muscle. Osteocytes are multifunctional cells that regulate bone remodeling 
through osteoblasts and osteoclasts, act as endocrine cells targeting other tissues, regulate 
both calcium and phosphate homeostasis, and also act as mechanosensory cells that signal 
for bone removal with disuse and bone formation with anabolic loading (Bonewald, 2011; 
Dallas et al., 2013).
Programmed osteocyte cell death is necessary to repair damaged bone (Kennedy et al., 2012; 
Verborgt et al., 2000, 2002). This type of osteocyte cell death acts as a beacon to direct 
osteoclasts to the microdamaged bone for removal as the osteocytes sacrifice themselves in 
order to repair bone. This process is highly programmed to release factors, such as RANKL, 
to direct osteoclasts to damaged sites for repair. Therefore, it is important to maintain the 
health and function of the osteocyte to maintain bone homeostasis. However, as we age, 
these cells begin to die and their remains are removed and lost through the lacuno-
canalicular system, leaving empty lacunae, or the dying cells can vesiculate and 
micropetrose, resulting in a mineralized filling in of their lacunae (for reviews on osteocytes, 
see Bonewald, 2011 and Dallas et al., 2013). This results in a compromised lacuno-
canalicular system with impaired osteocyte signaling.
BAIBA was reported to bind to glycine receptors and to the MRGPRD, which is also known 
to be a receptor for β-alanine, and the neurotransmitter GABA (Uno et al., 2012). The 
Mrgprd is most highly expressed in nonpeptidergic dorsal root ganglia neurons (Zylka et al., 
2005) and found to be the sensory receptor for irritation, such as noxious mechanical stimuli 
(Cavanaugh et al., 2009). Protein expression was only found in dorsal root ganglia (McNeil 
and Dong, 2014), but low mRNA levels were detected in bladder, uterus, testes, arteries, and 
femur (Shinohara et al., 2004). We found that an MRGPRD antagonist, MU6840 (Uno et al., 
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2012), blocked the beneficial effect of L-BAIBA ROS-induced cell death, as did both siRNA 
and sgRNA to Mrgprd. Whereas muscle from both young, 5-month-old, and 22-month-old 
mice produce BAIBA in response to contraction, osteocytes from old mice are not protected 
by BAIBA to the same extent as young osteocytes. Mrgprd was highly expressed in young 
osteocytes but decreased in expression in old osteocytes. This suggests that osteocytes lose 
their response to BAIBA with aging. Aged contracted muscle can produce BAIBA in 
response to exercise, but the reduction in receptor expression may reduce the beneficial 
effects of exercise on osteocytes.
A number of factors have been shown to induce osteocyte cell death, including 
glucocorticoids and cytokines such as IL-1 and TNF-α. Conversely, a number of molecules 
have been shown to protect osteocytes from cell death, including estrogen and 
bisphosphonates (for review, see Bellido and Plotkin, 2011; Jilka et al., 2013; Jilka and 
O’Brien, 2016). We showed that secreted muscle factors could protect osteocytes from 
glucocorticoid-induced cell death and that this effect was mediated through the β-catenin-
signaling pathway (Jähn et al., 2012). It has been suggested that oxidative stress caused by 
disuse, estrogen deficiency, excess corticosterone, and aging may be responsible for bone 
cell death and, therefore, bone fragility (Almeida and O’Brien, 2013). Here we performed 
studies examining the effects of ROS, known to be generated with aging, on osteocyte 
viability. Mitochondria play a crucial role in cell survival. Mitochondria require ROS for 
normal function (Holzerová and Prokisch, 2015), but with aging excess ROS leads to 
mitochondrial breakdown (Finkel, 2015; Valko et al., 2007). During apoptosis, alteration of 
mitochondrial structure and reduction of membrane potential are present. Mitochondria 
show massive fragmentation of their network associated with cytochrome c release, which 
induces the formation of the apoptosome leading to activation of caspase-3, responsible for 
apoptosis (Langlais et al., 2015). We were able to image mitochondria in both MLO-Y4 
cells and primary osteocytes, showing trafficking similar to that observed in axonal neural 
cells (Rinholm et al., 2016). Here we show that BAIBA prevented or reduced this massive 
breakdown of mitochondria induced by H2O2 in MLO-Y4 osteocyte-like cells.
As BAIBA production is increased with exercise (Roberts et al., 2014) and with contraction 
of isolated EDL and soleus as shown in this study, the hindlimb unloading assay, a model of 
disuse or lack of exercise, was performed to determine the effects of L-BAIBA on both bone 
and muscle. The detrimental effects of unloading on bone mass through osteocytes are well 
described (Basso and Heersche, 2006), and it has previously been shown that blocking 
osteocyte apoptosis prevents bone loss due to hindlimb unloading (Cabahug-Zuckerman et 
al., 2016). We found that providing L-BAIBA in drinking water for 2 weeks of hindlimb 
unloading retained bone mass, more so in males than females, most likely due to the greater 
amount of trabecular bone in males compared to females even with using 3-month-old 
females as compared to 5-month-old males. By histomorphometric analysis, more bone was 
retained in males given L-BAIBA, but this was not observed in females, most likely due to 
the low amount of trabecular bone, which can be more easily quantitated using 3-
dimensional μCT, but not 2-dimensional bone histomorphometry. Also, significantly greater 
apoptosis was observed in osteocytes in the untreated as compared to the L-BAIBA-treated 
animals, whereas no differences were observed in mRNA for the osteocyte factors, 
sclerostin, Rankl, or osteoprotegerin. These data suggest that L-BAIBA protects both 
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osteoblasts and osteocytes through maintenance of viability and not through regulation of 
osteoblasts via sclerostin and osteoclasts via Rankl/Opg. L-BAIBA could potentially be 
exerting a direct effect on osteoblasts, but, as osteocytes express much higher levels of 
Mrgprd, the effects on osteoblasts could be indirect through the maintenance of osteocyte 
viability.
Male mice treated with L-BAIBA during hindlimb unloading retained EDL muscle mass and 
maximal contractile force over controls, however, EDL maximal force normalized to muscle 
size was similar between groups, indicating that the higher EDL mass in the L-BAIBA-
treated group accounted for the higher contractile force. Soleus muscles from L-BAIBA-
treated mice displayed higher contractile force and rate of force development at stimulatory 
frequency, which produces approximately half of maximal contractile force output (40 Hz) 
as well as a leftward shift in the force-frequency curve at 40–80 Hz over controls. The force-
frequency profile is indicative of muscle fiber myosin heavy chain (MHC) composition, with 
slow type 1 muscle fibers displaying higher Ca2+ sensitivity as well as the higher rates of 
calcium sarcoplasmic reticulum (SR) release at these lower frequencies of stimulation and, 
therefore, higher relative forces at suboptimal frequencies compared to fast type 2 MHC-
enriched muscle fibers. Enhanced muscle contractility at these lower frequencies is very 
physiologically relevant, especially when considering that mammalian skeletal muscles 
normally function in this range (Edwards et al., 1977a, 1977b). These studies also 
demonstrate that muscle mass does not necessarily directly correlate with function, 
therefore, function can be preserved despite no gains in muscle mass. Interestingly, EDL and 
soleus muscles from female mice were virtually unaffected by L-BAIBA treatment. These 
differences in response to L-BAIBA could be due to the combined effects of higher estrogen 
expression levels and lower testosterone concentrations in combination with the higher 
docosahexaenoic acid (DHA) in the female’s body, as observed in humans (Bakewell et al., 
2006; Giltay et al., 2004).
Based on these observations, one might speculate that BAIBA may exert not only direct 
effects on bone cells but also indirect effects by preserving muscle that directly loads the 
tibia, especially in male mice. Retention or preservation of both mechanical stimuli and 
secreted myokines such as BAIBA may act together to preserve bone mass. In the EDL 
muscle composed of different muscle fiber types, L-BAIBA may be acting through 
preservation of muscle mass. Muscle disuse is known to lead to shifts in MHC expression 
from slow MHC type 1 to faster MHC type 2 isoforms in slow-twitch muscles like the 
soleus. BAIBA has been found to induce expression of peroxisome proliferator-activated 
receptor delta (PPARδ) in skeletal muscle (Jung et al., 2015), a known regulator of slow type 
1 muscle fiber development/maintenance (Ehrenborg and Krook, 2009). This suggests that 
L-BAIBA may attenuate disuse-induced fiber type switching in soleus muscle via the 
induction of PPARδ expression. The autocrine effects of BAIBA on muscle will require 
additional investigation, especially in the context of bone and muscle crosstalk.
In summary, we have identified another function for the muscle-derived metabolite L-
BAIBA on osteocyte viability. L-BAIBA protects osteocytes from ROS-induced apoptosis 
through the MRGPRD and through maintaining mitochondria integrity. This protective 
capacity appears lost with aging due to the downregulation of Mrgprd expression in 
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osteocytes. Therefore, targeting receptor expression in osteocytes with aging may return the 
bone anabolic response to exercise.
EXPERIMENTAL PROCEDURES
Please refer to the Supplemental Experimental Procedures for a detailed description of other 
experiments.
MLO-Y4 Cells
The osteocyte-like MLO-Y4 cell line, derived from murine long bone, was used as an in 
vitro osteocyte model (Kato et al., 1997). MLO-Y4 cells were maintained on collagen type 
I-coated plates in α-MEM supplemented with 2.5% fetal bovine serum (FBS), 2.5% calf 
serum (CS), and 100 U/mL penicillin/streptomycin (P/S) in a 5% CO2 incubator at 37°C. 
For all assays, phenol red-free a-MEM was used.
Isolation of Primary Bone Cells from Mouse Long Bones
Primary bone cells were isolated as previously described with some modifications (Stern et 
al., 2012). Briefly, long bones were dissected from 5- or 22-month-old C57BL/6 male mice 
for cell death assay and from 3-month-old DMP1-GFP female mice for live imaging. After 
removal of soft tissue, epiphyses were cut off and bones were flushed with PBS using a 
27G½ needle-syringe to remove bone marrow. Bones were then longitudinally cut and 
digested 3 times with 300 U/mL collagenase type IA (Sigma-Aldrich, C9891), one time with 
5 mM EDTA (Sigma-Aldrich, E5134)/0.1% BSA (Sigma-Aldrich, A7030), and one more 
with the collagenase, each for 25 min at 37°C. The bones were minced into small pieces and 
cultured in 5% FBS/5% CS/α-MEM in a 6-well plate coated with 0.15 mg/mL rat tail 
collagen type I (Corning, 354236) until primary bone cells were obtained as an outgrowth 
from the bone chips.
Quantification of Cell Death
MLO-Y4 cells or primary bone cells obtained from long bones were plated at 1−1.25 × 
104/cm2 on a collagen-coated 96-well plate with 6 wells for each experimental condition. 
Representative examples of two or four independent experiments are shown. Cells were 
pretreated with varying concentrations of L/D-BAIBA (Sigma-Aldrich, 217794), L-BAIBA 
(Sigma-Aldrich, 51511), D-BAIBA (Sigma-Aldrich, 68337), β-estradiol (Sigma-Aldrich, 
E8875), NAC (Sigma-Aldrich, A7250), β-alanine (Sigma-Aldrich, 146064), or GABA 
(Sigma-Aldrich, A2129) in 1% FBS/1% CS/α-MEM for 1 or 24 hr, followed by treatment 
with 0.3 mM hydrogen peroxide (EMD Millipore, HX0635-3) for 3–4 hr in 0.5% FBS/0.5% 
CS/α-MEM to induce 20%–40% cell death. The cells were pretreated with MU6840 (Key 
Organics, 5R-0328) for 30 min before adding L-BAIBA. Cells were stained with 2 μM 
ethidium homodimer 1 (EthD-1, Invitrogen, E1169) for 30 min and analyzed on a Nikon 
Eclipse TE300 inverted fluorescence microscope to detect dead cells. Images were acquired 
under 10× magnification using epifluorescence illumination with a Photometrics Coolsnap 
EZ cooled charge-coupled device (CCD) camera interfaced with ImageJ, and we quantified 
thresholded images using a function of particle analyzer in ImageJ (NIH). Percentage of cell 
death was calculated as EthD-1-positive cells divided by the total number of cells stained 
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with 5 μg/mL Hoechst 33342 (Invitrogen, H1399) as a nuclear counterstain. Data are 
presented as fold change over the level of cell death in the sample treated with hydrogen 
peroxide alone.
Mice
2.5-, 3-, 5-, and 22-month-old C57BL/6 female and male mice were obtained from Charles 
River or the National Institute of Aging animal colony. All animal experiments were 
performed according to an approved Institutional Animal Care and Use Committee protocol 
at the University of Missouri-Kansas City (UMKC), conforming to relevant federal 
guidelines. The UMKC animal facility is operated as a specific pathogen-free, AAALAC-
approved facility. Animal care and husbandry meet the requirements in the Guide for the 
Care and Use of Laboratory Animals by the National Research Council. Animals were 
group housed and maintained on a 12-hr light/dark cycle with ad libitum food and water at a 
constant temperature of 23°C. Daily health check inspections were performed by qualified 
veterinary staff and/or animal care technicians.
Hindlimb Unloading with or without L-BAIBA
Paired 5-month-old male mice from the same litter (total 6 pairs from 3 litters) or paired 3-
month-old female mice from the same litter (total 6 pairs from 4 litters) were assigned to 
either control or treated and housed in one large cage (10 × 19 × 11 in., 190 in2 floor space). 
We chose 3-month-old female mice since by 5 months of age most of the trabecular bone is 
gone, while sufficient for quantitation at 3 months. They show 15%–50% lower values in 
trabecular bone parameters compared to 5-month-old male mice. The animals were weight-
matched (male/control, 34.11 ± 4.20 g; L-BAIBA, 34.35 ± 4.23 g; female/control, 21.54 
± 1.08 g; L-BAIBA, 21.37 ± 1.88 g). L-BAIBA (100 mg/kg/day, AdipoGen Life Sciences) 
was provided in drinking water ad libitum, and the amounts consumed were similar in both 
control (male, 7.76 ± 0.55 mL; female, 6.88 ± 0.08 mL) and treated mice (male, 8.13 ± 0.73 
mL; female, 6.97 ± 0.06 mL). L-BAIBA intake was 106.75 ± 12.04 and 129.91 ± 6.24 
mg/kg/day for male and female, respectively. Hindlimb unloading was carried out for 2 
weeks as described previously (Ferreira et al., 2011), with some modifications (Maurel et al., 
2016). Mice were suspended by a tail ring surgically inserted through inter-vertebral disc 
space. The tail ring was attached to the tail with a supportive steel wire by strips of adhesive 
tape for reinforcement. This system allows a 360-degree range of motion while maintaining 
approximately a 30-degree angle between the body axis and cage bottom to prevent the 
contact of hindlimbs to the floor.
After 2 weeks of hindlimb unloading, EDL and soleus were dissected for ex vivo muscle 
contractility analysis. The right tibia was dissected for ex vivo μCT and the left tibia for 
bone histomorphometry. Both femurs were used for real-time PCR after flushing bone 
marrow.
Live Imaging of Osteocyte Mitochondria
Confocal imaging of cultured osteocytes was conducted using a Leica TCS SP8 confocal 
microscope equipped with a 40×, 1.2W (water immersion) objective. Primary bone 
osteocytes from DMP1-GFP mice or MLO-Y4 cells were incubated with 200 nM 
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MitoTracker Deep Red FM (Invitrogen, M22426) for 30 min at 37°C, for visualization of 
mitochondrial morphology and dynamics, or incubated with 50 nM TMRE (Invitrogen, 
T669) for 10 min at 37°C, for monitoring mitochondrial inner membrane potential as 
previously described (Wang et al., 2018; Yi et al., 2011; Zhou et al., 2010). MitoTracker 
Deep Red FM was excited at 633 nm and its emitted fluorescence was collected at 640–690 
nm. TMRE was excited at 543 nm with the fluorescence collected at 560–620 nm. The live-
cell imaging was conducted at room temperature. NIH ImageJ software was used for 
imaging processing and quantification of the fluorescence intensity of TMRE and 
MitoTracker Deep Red.
Statistical Analysis
Data were expressed as means ± SD. The statistical significance of the difference between 
mean values was determined by the following statistical methods, using Prism 7.0 
(GraphPad) or IBM SSPS Statistics: muscle CM analysis, multifactorial ANOVA followed 
by simple effect test with least significant difference (LSD); μCT and bone 
histomorphometry analyses, one-tailed paired t test for analyzing in vivo and ex vivo μCT 
and bone histomorphometry data and paired t test or two-way ANOVA followed by sidak 
post hoc test for EF classification; muscle contraction analysis, data were statistically 
analyzed with one-tailed paired t test and two-way ANOVA followed by sidak post hoc test; 
quantification of cell death and ROS, one-way ANOVA followed by tukey post hoc test; 
real-time qPCR, one-tailed paired t test or multifactorial ANOVA followed by simple effect 
test with LSD. Differences were considered significant at p < 0.05.
Data and Accessibility
The original raw data this work have been deposited at Mendeley Data and are available at 
https://doi.org/10.17632/gydsk6dvm2.1
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Refer to Web version on PubMed Central for supplementary material.
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Highlights
• The muscle metabolite L-BAIBA protects osteocytes from ROS-induced cell 
death
• L-BAIBA prevents mitochondrial breakdown in osteocytes
• The effects of L-BAIBA are mediated via MRGPRD that decreases with 
aging
• In vivo, L-BAIBA reduces bone and muscle loss resulting from 
immobilization
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Figure 1. L-BAIBA Protects Osteocytes from Cell Death Induced by Oxidative Stress
(A) Cell death assay using the osteocyte cell line MLO-Y4. L-BAIBA as well as L/D-
BAIBA, but not D-BAIBA, showed highly significant protective effects on MLO-Y4 cell 
death induced by oxidative stress. ***p < 0.001 versus H2O2.
(B) Comparison of potency between L-BAIBA and well-known antioxidants β-estradiol and 
N-acetylcysteine (NAC) on MLO-Y4 cell death induced by oxidative stress. **p < 0.01 and 
***p < 0.001 versus H2O2.
(C) Prevention by L-BAIBA of reactive oxygen species (ROS) generation induced by 
oxidative stress. *p < 0.05 and ***p < 0.001 versus H2O2.
(D) Induction of antioxidant enzymes, catalase, and Gpx4 by L-BAIBA. **p < 0.01 and 
***p < 0.001 versus control.
The data are expressed as the mean ± SD. See also Figures S1–S3.
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Figure 2. L-BAIBA Maintains Trabecular Bone Mass and Connectivity after 2 Weeks of 
Hindlimb Unloading
(A–J) μCT analysis of cancellous bones in right proximal tibiae, in vivo (A–E) and ex vivo 
(F–J). Bone volume fraction (BV/TV) (A and F), trabecular number (Tb.N) (B and G), 
trabecular thickness (Tb.Th) (C and H), trabecular separation (Tb.Sp) (D and I), and 
connectivity density (Conn.D) (E and J) were examined. Upper panel is for the 5-month-old 
male (n = 6) and lower panel is for the 3-month-old female (n = 6). All the parameters in 
vivo μCT are expressed as a percentage of baseline. *p < 0.05 and **p < 0.01 versus control.
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(K–N) Ellipsoid factor (EF) classification for rod/plate geometry. Representative 3D color 
map images of control and L-BAIBA (K) indicate EF > 0 in orange-yellow (rod type) and 
EF < 0 in purple-blue (plate type). Corresponding EF histograms of control and L-BAIBA 
(L) indicate a shift to the left for plate-dominated structures and to the right for rod-
dominated structures. Mean of EF (M) and summary of EF histograms (N) are shown. 5-
month-old male, n = 6; 3-month-old female, n = 6. **p < 0.01 and ***p < 0.001 versus 
control.
The data are expressed as the mean ± SD.
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Figure 3. L-BAIBA Maintains Trabecular Bone Mass and Osteocyte Viability after 2 Weeks of 
Hindlimb Unloading
(A–H) Bone static histomorphometry of cancellous bones in left proximal tibiae, in vivo. 
Bone volume fraction (BV/TV) (A), trabecular number (Tb.N) (B), trabecular thickness 
(Tb.Th) (C), trabecular separation (Tb.Sp) (D), osteoblast surface (Ob.S/BS) (E), osteoblast 
number (N.Ob/B.Pm) (F), osteoclast surface (Oc.S/BS) (G), and osteoclast number (N.Oc/
B.Pm) (H) were examined. Upper panel is for the 5-month-old male (n = 6) and lower panel 
is for the 3-month-old female (n = 6). *p < 0.05 and **p < 0.01 versus control.
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(I) Osteocyte viability evaluated by TUNEL apoptosis assay with 5-month-old male (n = 6) 
and 3-month-old female (n = 6). *p < 0.05 versus control.
(J) Real-time qPCR analysis of Sost, Rankl, and Opg mRNA expression in femurs obtained 
from hindlimb unloaded male mice (n = 6). Data are expressed as fold change over the 
expression level of each gene in control mice (average Ct value is 27 for Sost, 37 for Rankl, 
and 31 for Opg). No significant difference was detected compared to control.
The data are expressed as the mean ± SD.
Kitase et al. Page 23
Cell Rep. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. L-BAIBA Maintains EDL and Soleus Muscle Function after 2 Weeks of Hindlimb 
Unloading
(A–L) EDL and soleus muscle functional analysis, EDL (A–F) and soleus (G–L). Half-
maximal (1/2 Tmax) and maximal tetanic contractions (Tmax) are shown in left and right 
panels, respectively. Upper panel is for the 5-month-old male (n = 6) and lower panel is for 
the 3-month-old female (n = 6). Muscle mass (A and G), muscle force (B and H), muscle-
specific force (C and I), muscle rate of contractile force development (D and J), muscle 
relaxation (E and K), and muscle relative force (F and L) are examined. Relative force is a 
force versus frequency relationship among the stimulatory frequencies of 1–200 Hz, wherein 
force at each frequency is expressed as a percentage of Tmax. *p < 0.05 and **p < 0.01 
versus control.
The data are expressed as the mean ± SD.
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Figure 5. L-BAIBA Is Secreted by Both Young and Old Contracted Muscle but Only Protects 
Young, but Not Old, Primary Osteocytes from Cell Death Induced by Oxidative Stress
(A) L-BAIBA production by ex vivo contracted muscle at 90 Hz. The amount of L-BAIBA 
was normalized by muscle mass. a, versus corresponding non-contracted muscle CM; b, 
versus corresponding contracted muscle CM obtained from 5-month-old mice; c, versus 
corresponding contracted muscle CM obtained from female mice; d, versus contracted EDL 
muscle CM obtained from 22-month-old male mice; p < 0.05.
(B and C) Cell death assay of primary bone cells from long bones. L/D-BAIBA (B) and L-
BAIBA (C) protect primary bone cells obtained from 5-month-old male mice (upper panel) 
under oxidative stress, but not the ones from 22-month-old male mice (lower panel). *p < 
0.05 and ***p < 0.001 versus H2O2.
The data are expressed as the mean ± SD. See also Figure S4.
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Figure 6. The Protective Effects of L-BAIBA on Osteocyte Viability Are Mediated through the 
MRGPRD
(A and B) Real-time qPCR analysis of Mrgprd (A) and Glra4/b (B) mRNA expression in 
primary osteoblast fractions and osteocyte-enriched bones obtained from male and female at 
2.5, 5, and 22 months old. Data are expressed as fold change over the Mrgprd expression 
level in primary osteoblast fractions obtained from 5-month-old female mice (average Ct 
value is 30). Glra1–3 are undetectable. a, versus 5-month-old female primary osteoblast 
fraction (pObF); b, versus 5-month-old male pObF; c, versus 5-month-old female osteocyte-
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enriched bones (pOcyB); d, versus 5-month-old female pOcyB; e, versus 5-month-old male 
pOcyB; p < 0.05.
(C) Real-time qPCR analysis of Mrgprd and Glra4/b mRNA expression in MLO-Y4 cells. 
Data are expressed as fold change over the Mrgprd expression level (average Ct value is 33). 
Glra1–3 are undetectable.
(D) Comparison of L-BAIBA with other MRGPRD ligands, β-alanine, GABA, and glycine 
in cell death assay. **p < 0.01 and ***p < 0.001 versus H2O2.
(E) An antagonist against MRGPRD, MU6840 prevents the protective effect of L-BAIBA on 
osteocyte viability. ***p < 0.001 versus H2O2.
(F) Real-time qPCR analysis to determine the efficiency of Mrgprd knockdown using RNAi 
system. Data are expressed as fold change over the expression level in parental MLO-Y4.
(G) Mrgprd knockdown by siRNA prevents the protective effect of L-BAIBA on osteocyte 
viability. ***p < 0.001 versus vehicle/H2O2, ###p < 0.001 versus negative control/H2O2, 
and +++p < 0.001 versus Mrgprd siRNA/H2O2.
(H) Western blot analysis to determine the efficiency of Mrgprd knockout using CRISPR/
Cas9 system. Data are normalized by β-actin and expressed as fold change over the 
expression level in parental MLO-Y4.
(I) Mrgprd knockout by CRISPR/Cas9 prevents the protective effect of L-BAIBA on 
osteocyte viability. **p < 0.01 and ***p < 0.001 versus negative control/H2O2 and ###p < 
0.001 versus MRGPRD2/H2O2.
The data are expressed as the mean ± SD.
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Figure 7. Confocal Microscopy Images of Mitochondrial Response to Acute Treatment of 
Hydrogen Peroxide in Live Cells, Prevention of Mitochondrial Breakdown by L-BAIBA
(A) Mitochondria in a primary osteocyte (top) and a MLO-Y4 cell (bottom).
(B) Time-lapse confocal imaging of mitochondria in MLO-Y4 cell after treatment with 
hydrogen peroxide (100 μM) alone (top row) and with 100 μM hydrogen peroxide plus L-
BAIBA (bottom row).
(C and D) Evaluation of mitochondrial membrane potential using TMRE (red) and structure 
using Mito Red (green) with the treatment of hydrogen peroxide alone (C) and of hydrogen 
peroxide plus L-BAIBA (D). Arrow indicates the time that hydrogen peroxide was added.
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(E–G) Quantification of the change of fluorescent intensity (TMRE) over the time per cell 
before and after treating with hydrogen peroxide (E), hydrogen peroxide plus L-BAIBA (F), 
and average fluorescence intensity of TMRE (n = 5) (G). Arrow indicates the time that 
hydrogen peroxide was added. Scale bar, 10 μm. See also Figure S5.
Kitase et al. Page 29
Cell Rep. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
